Gilead Sciences Inc (GILD)

60.79 +0.12  +0.20% NASDAQ Oct 23, 20:00 USD

Gilead Sciences Cash from Investing (Quarterly):

-5.023B for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (Quarterly) Data

View and export this data going back to 1992. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 -5.023B
March 31, 2020 -344.00M
Dec. 31, 2019 431.00M
Sept. 30, 2019 -1.841B
June 30, 2019 -6.163B
March 31, 2019 -244.00M
Dec. 31, 2018 2.735B
Sept. 30, 2018 2.025B
June 30, 2018 5.241B
March 31, 2018 4.354B
Dec. 31, 2017 -10.02B
Sept. 30, 2017 -2.114B
June 30, 2017 -4.246B
March 31, 2017 307.00M
Dec. 31, 2016 -2.675B
Sept. 30, 2016 -3.917B
June 30, 2016 -3.284B
March 31, 2016 -2.109B
Dec. 31, 2015 -2.438B
Sept. 30, 2015 -4.186B
June 30, 2015 -3.552B
March 31, 2015 -2.299B
Dec. 31, 2014 -405.00M
Sept. 30, 2014 -770.00M
June 30, 2014 -487.00M
   
March 31, 2014 -161.00M
Dec. 31, 2013 216.76M
Sept. 30, 2013 -8.032M
June 30, 2013 -55.48M
March 31, 2013 -407.26M
Dec. 31, 2012 50.12M
Sept. 30, 2012 -518.04M
June 30, 2012 -634.96M
March 31, 2012 -10.74B
Dec. 31, 2011 4.440B
Sept. 30, 2011 -80.32M
June 30, 2011 -469.79M
March 31, 2011 -300.38M
Dec. 31, 2010 -407.82M
Sept. 30, 2010 -1.394B
June 30, 2010 932.97M
March 31, 2010 -1.069B
Dec. 31, 2009 -397.68M
Sept. 30, 2009 -426.65M
June 30, 2009 -1.063B
March 31, 2009 -328.39M
Dec. 31, 2008 238.58M
Sept. 30, 2008 -319.08M
June 30, 2008 24.90M
March 31, 2008 -123.22M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Benchmarks

Regeneron Pharmaceuticals Inc 1.453B
Moderna Inc 12.48M
Amgen Inc -2.159B

Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -10.02B Dec 2017
Maximum 5.241B Jun 2018
Average -1.543B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.